Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
McKinsey
Dow
Merck
Baxter

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Atiprimod

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Atiprimod?

Atiprimod is an investigational drug.

There have been 5 clinical trials for Atiprimod. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2006.

The most common disease conditions in clinical trials are Carcinoma, Neuroendocrine, Carcinoma, and Neoplasms. The leading clinical trial sponsors are Callisto Pharmaceuticals, M.D. Anderson Cancer Center, and [disabled in preview].

Recent Clinical Trials for Atiprimod
TitleSponsorPhase
Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine CarcinomaCallisto PharmaceuticalsPhase 2
Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine CarcinomaCallisto PharmaceuticalsPhase 2
An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced CancerCallisto PharmaceuticalsPhase 1/Phase 2

See all Atiprimod clinical trials

Clinical Trial Summary for Atiprimod

Top disease conditions for Atiprimod
Top clinical trial sponsors for Atiprimod

See all Atiprimod clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Harvard Business School
Baxter
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.